GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri

$330,151
Steven K. Libutti · University Of Texas Hlth Sci Ctr Houston · U54 · FY2014 · CA

Role of Mitochondrial Respiratory Stress Signaling in Cancer Progression

$330,150
Narayan G Avadhani · University Of Pennsylvania · R01 · FY2011 · CA

Human Ribonuclease as a Cytotoxin

$330,103
Ronald T Raines · Massachusetts Institute Of Technology · R01 · FY2024 · CA

TGF-beta Signaling in Pancreatic Cancer Progression

$330,091
Christine A Iacobuzio-Donahue · Johns Hopkins University · R01 · FY2011 · CA

TGF-beta Signaling in Pancreatic Cancer Progression

$330,091
Christine A Iacobuzio-Donahue · Johns Hopkins University · R01 · FY2012 · CA

Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development

$330,091
Barry D. Nelkin · Johns Hopkins University · R01 · FY2012 · CA

Targeting CDK5 in Pancreatic Cancer: Mechanistic and Preclinical Development

$330,091
Barry D. Nelkin · Johns Hopkins University · R01 · FY2011 · CA

Preclinical platform for theranostic nanoparticles in pancreatic cancer

$330,019
Nancy J Halas · Rice University · U01 · FY2014 · CA

Measurement of 2D receptor-ligand binding kinetics under flow

$330,000
Konstantinos Konstantopoulos · Johns Hopkins University · · FY2012 · ENG

Mechanism of Pancreatic Carcinogenesis

$329,991
Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R01 · FY2019 · CA

HORMONES: BIOCHEMISTRY AND MOLECULAR BIOLOGY

$329,977
Max Elliot Gottesman · Columbia University Health Sciences · T32 · FY2012 · DK

Gq-coupled Receptors Inhibit PI 3-kinase/Akt Signaling Pathway

$329,938
Richard Z Lin · State University New York Stony Brook · R01 · FY2010 · DK

The Role of WSB1 in Tumorigenesis

$329,925
Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2017 · CA

Novel Experimental Therapeutics for Pancreatic Cancer

$329,925
Gwen Lomberk · Mayo Clinic Rochester · R01 · FY2015 · CA

The Role of WSB1 in Tumorigenesis

$329,925
Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2016 · CA

The Role of WSB1 in Tumorigenesis

$329,925
Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2014 · CA

The Role of WSB1 in Tumorigenesis

$329,925
Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2015 · CA

Novel Experimental Therapeutics for Pancreatic Cancer

$329,925
Gwen Lomberk · Mayo Clinic Rochester · R01 · FY2016 · CA

Novel Experimental Therapeutics for Pancreatic Cancer

$329,925
Gwen Lomberk · Mayo Clinic Rochester · R01 · FY2014 · CA

The Role of WSB1 in Tumorigenesis

$329,925
Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2018 · CA

Machine learning, network-based models for gene expression, activity, function

$329,917
Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Aspects of MUC13 Mucin in Cancer

$329,906
Subhash C. Chauhan · Sanford Research/Usd · R01 · FY2010 · CA

Kinetic analysis of Myc-induced carcinogenesis in vivo

$329,901
Gerard Ian Evan · University Of California, San Francisco · R01 · FY2011 · CA

Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma

$329,848
Juan Luis Vivero-Escoto · University Of North Carolina Charlotte · R01 · FY2023 · CA

OPN neutralization monoclonal antibody 100G2 for human pancreatic cancer immunotherapy

$329,610
Priscilla Simon Redd · Chemedimmune, Inc. · R43 · FY2020 · CA